Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 3/20 | 0.45 |
| ▸ | BRD4 | O60885 | 4/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 3/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.43 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.39 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.39 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1734662 | 1.00 | MTNR1A (0.45) | MTNR1ABRD4CREBBPEP300SMYD3 | |
| SCHEMBL29683355 | 1.00 | MTNR1A (0.45) | MTNR1ABRD4CREBBPEP300SMYD3 | |
| SCHEMBL29641564 | 1.00 | MTNR1A (0.45) | MTNR1ABRD4CREBBPEP300SMYD3 | |
| SCHEMBL4130897 | 1.00 | MTNR1A (0.45) | MTNR1ABRD4CREBBPEP300SMYD3 | |
| Ammonia Solution, Strong SCHEMBL5054545 | 0.98 | MTNR1A (0.44) | MTNR1ABRD4CREBBPEP300SMYD3 | |
| SCHEMBL166058 | 0.88 | MAPT (0.43) | MTNR1ABRD4CREBBPEP300NPC1 | |
| SCHEMBL23812633 | 0.85 | TSHR (0.41) | MTNR1ABRD4CREBBPEP300NPC1 | |
| SCHEMBL22383643 | 0.80 | MTNR1A (0.43) | MTNR1ABRD4CREBBPSMYD3NPC1 | |
| SCHEMBL19774297 | 0.78 | MTNR1A (0.47) | MTNR1ASMYD3NPC1MAPK13MAPK12 | |
| SCHEMBL1736809 | 0.78 | CREBBP (0.55) | BRD4CREBBPEP300TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 754 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581069-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | Henkel AG & Co. KGaA (DE) | 2025-07-09 | — | — | EP | claimed |
| US-20250197690-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2025-06-19 | — | — | US | claimed |
| CN-118204084-A | Preparation method of silicon oxide modified metal-based catalyst and application of silicon oxide modified metal-based catalyst in preparation of cyclic amine compounds | 浙江恒逸石化研究院有限公司 | 2024-06-18 | — | — | CN | claimed |
| WO-2024046703-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2024-03-07 | — | — | WO | claimed |
| EP-4326789-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | Henkel AG & Co. KGaA (DE) | 2024-02-28 | — | — | EP | claimed |
| US-20240052219-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2024-02-15 | — | — | US | claimed |
| US-11891512-B2 | Redox curable compositions and methods of manufacture thereof | HENKEL AG & CO. KGAA (DE) | 2024-02-06 | — | — | US | claimed |
| CN-116621776-A | Preparation method of 2-methylquinoline | 遵义医科大学 | 2023-08-22 | — | — | CN | claimed |
| CN-116376858-A | Application of monoamine oxidase from microorganism as catalyst in preparation of quinoline or quinoline derivative | 浙江大学杭州国际科创中心 | 2023-07-04 | — | — | CN | claimed |
| US-20230147662-A1 | REDOX CURABLE COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF | HENKEL AG & CO. KGAA (DE) | 2023-05-11 | — | — | US | claimed |
| WO-2012112758-A2 | VIRTUAL HYDROGEN STORAGE PROCESSES AND RELATED CATALYSTS AND SYSTEMS | YALE UNIVERSITY (US) | 2012-08-23 | — | — | WO | claimed |
| WO-2009024095-A1 | METHOD OF MAKING AND ADMINISTERING QUINOLINE DERIVATIVES AS ANTI-CANCER AGENTS | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2009-02-26 | — | — | WO | claimed |
| US-20090054482-A1 | Method of making and administering quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2009-02-26 | — | — | US | claimed |
| EP-0495250-B1 | Cationic 1,3,4 thiadiazole dyes | BAYER AG (DE) | 1996-01-31 | — | — | EP | claimed |
| EP-0495250-A1 | Cationic 1,3,4 thiadiazole dyes | BAYER AG (DE) | 1992-07-22 | — | — | EP | claimed |
| US-4460760-A | ADHESIVES | OKURA KOGYO KABUSHIKI KAISHA (JP) | 1984-07-17 | — | — | US | claimed |
| US-4447563-A | Anaerobically curable composition and process for preparation thereof | OKURA KOGYO KABUSHIKI KAISHA (JP) | 1984-05-08 | — | — | US | claimed |
| EP-0006540-B1 | N-DICHLOROACETYL-1,2,3,4-TETRAHYDROQUINALDINE, PROCESS FOR OBTAINING IT, ITS USE FOR PREVENTING CROPS FROM BEING DAMAGED BY HERBICIDES AND SELECTIVE HERBICIDAL COMPOSITIONS BASED ON N-DICHLOROACETYL-1,2,3,4-TETRAHYDROQUINALDINE AND HERBICIDAL ACETANILIDES OR THIOLCARBAMATES | BAYER AG (DE) | 1981-10-07 | — | — | EP | claimed |
| EP-0023306-A1 | N-(Alpha-chloropropionyl)-1,2,3,4-tetrahydro-quinaldine, process for its preparation and its use as antidote in preventing damage to crops by herbicides | BAYER AG (DE) | 1981-02-04 | — | — | EP | claimed |
| EP-0006540-A1 | N-Dichloroacetyl-1,2,3,4-tetrahydroquinaldine, process for obtaining it, its use for preventing crops from being damaged by herbicides and selective herbicidal compositions based on N-dichloroacetyl-1,2,3,4-tetrahydroquinaldine and herbicidal acetanilides or thiolcarbamates | BAYER AG (DE) | 1980-01-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054482-A1 | Method of making and administering quinoline derivatives as anti-cancer agents | HCCS, GLS2, NQO1 | MTNR1A 1442/4885BRD4 99/4885CREBBP 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.